The Motley Fool

1 stock to buy now for the ‘worst cold ever’

The content of this article was relevant at the time of publishing. Circumstances change continuously and caution should therefore be exercised when relying upon any content contained within this article.

A stock price graph showing growth over time, possibly in FTSE 100
Image source: Getty Images.

If, like me, you’re feeling under the weather, it might be comforting to know that you’re not alone. After nearly two years of limited social mixing, most restrictions are now lifted. Workers are commuting, face mask mandates are over, and family visits are back on. But the natural consequence is a resurgence of cold and flu viruses. And unfortunately it seems they’re back with a vengeance. However, there’s always a silver lining. For me, it’s this stock I’d buy now.

Reckitt Benckiser (LSE: RKT) has just posted much better-than-expected results, as demand for its brands, including Nurofen and Strepsils, has soared. In fact, its OTC (over-the-counter) “portfolio grew over 20% in the quarter, driven primarily by Mucinex sales, which benefited from a sharp improvement in cold and flu sales trends”. 

5 Stocks For Trying To Build Wealth After 50

Markets around the world are reeling from the coronavirus pandemic… and with so many great companies trading at what look to be ‘discount-bin’ prices, now could be the time for savvy investors to snap up some potential bargains.

But whether you’re a newbie investor or a seasoned pro, deciding which stocks to add to your shopping list can be a daunting prospect during such unprecedented times.

Fortunately, The Motley Fool UK analyst team have short-listed five companies that they believe STILL boast significant long-term growth prospects despite the global upheaval…

We’re sharing the names in a special FREE investing report that you can download today. And if you’re 50 or over, we believe these stocks could be a great fit for any well-diversified portfolio.

Click here to claim your free copy now!

Q3 results

Driven by high OTC demand, like-for-like sales rose 3.3% to over £3bn, while analyst consensus was an expected 0.7% drop. And full-year net revenue growth guidance is now up to between 1% and 3% year-on-year, compared to a Q2 estimate of between 0% and 2%. Encouragingly, the company has maintained its guidance on profit margins in the face of high inflation. But growth is expected to be slower than in 2020, when the global demand for cleaning products like its disinfectant brand Dettol saw revenue rise 12%.

However, with pubs, bars and nightclubs now all fully open, sales of its market leading Durex condoms brand also rose. The company said that “strong growth in intimate wellness continued, up mid-single-digits”. And as autumn turns to winter, the temptation of a warm pub surrounded by friends means punters will be more likely to need Reckitt Benckiser’s cold and flu remedies as well. 

A stock to buy now?

At 5,946p, the Reckitt Benckiser share price is up 6% in just five days. But it’s down 13% from 6,852p earlier this year. And with a five-year average of 6,551p, I think there’s significant upside potential for the stock. But it’s worth noting that its dividend yield for the past three years has been around 2.8%. And the FTSE 100 average is predicted to be around 4.1% in 2021. Therefore, it needs to see significant share price growth to beat the index return (and inflation).

And of course, Reckitt Benckiser has the same pressures as the rest of the FTSE 100. In its Q3 report, it warned that raw materials had increased in price by 10% over the quarter. And if it wants to maintain the same profit margins, then the prices it charges will have to rise. CEO Laxman Narasimhan has said that “there will be another round of pricing we will take to offset the inflation”. And with a cost of living crisis currently escalating, some consumers may not feel able to justify spending significantly more on branded products. 

But I think Reckitt Benckiser has such a large portfolio of widely used brands, that I’m confident it will be able to build on its latest performance. And I’m fairly sure that sales are going to rise in the short term. For me, it’s a stock to buy now. And my colleague, Christopher Ruane, agrees with me.

Free Report: 3 Shares To Try And Hedge Against Inflation

The Bank Of England has acknowledged that inflation is likely to peak above 4%, and stay there until the second quarter of 2022.

Some people are running scared, but if there’s one thing we believe you should avoid doing at all costs when inflation hits… it’s doing nothing.

That’s why we’ve put together a brand-new special report that uncovers 3 of our top UK and US share ideas to try and best hedge against inflation.

Because no matter what the economy is doing, a savvy investor will want their money working for them, inflation or not!

Best of all, we’re giving this report away completely FREE today!

Simply click here, enter your email address, and we’ll send it to you right away.

Charles Archer has no position in any of the shares mentioned. The Motley Fool UK has recommended Reckitt plc. Views expressed on the companies mentioned in this article are those of the writer and therefore may differ from the official recommendations we make in our subscription services such as Share Advisor, Hidden Winners and Pro. Here at The Motley Fool we believe that considering a diverse range of insights makes us better investors.

Our 6 'Best Buys Now' Shares

Renowned stock-picker Mark Rogers and his analyst team at The Motley Fool UK have named 6 shares that they believe UK investors should consider buying NOW.

So if you’re looking for more stock ideas to try and best position your portfolio today, then it might be a good day for you. Because we're offering a full 33% off your first year of membership to our flagship share-tipping service, backed by our 'no quibbles' 30-day subscription fee refund guarantee.

Simply click below to discover how you can take advantage of this.